Documents and Resources from the July 2, 2012
GlaxoSmithKline (GSK) Press ConferenceSpeech:
Deputy Attorney General James M. Cole Speaks at the GSK Press ConferencePress Release:
GlaxoSmithKline to Plead Guilty and Pay $3 Billion to Resolve Fraud Allegations and Failure to Report Safety DataCourt Documents
US Complaint
GSK Criminal Information
HHS-OIG Corporate Integrity Agreement
Civil Avandia Settlement Agreement
Civil Nominals Settlement Agreement
Civil Off Label Settlement Agreement
Government Complaint Exhibits
GSK Plea Agreement Exhibits
Plea Agreement
Plea Exhibit A
Plea Exhibit B
Plea Exhibit C
Plea Exhibit D
Plea Exhibit E
Plea Exhibit F
Plea Exhibit G
Plea Exhibit H
Plea Exhibit I
Plea Exhibit J
Plea Exhibit K
GSK Side Letter Exhibits
Side Letter
Side Letter Exhibit # 1
Side Letter Exhibit # 2
Side Letter Exhibit # 3
Side Letter Exhibit # 4
Side Letter Exhibit # 5
Side Letter Exhibit # 6
Side Letter Exhibit # 7
Side Letter Exhibit # 8
Due to public interest in this case, the Department of Justice is releasing documents that may not be in an accessible format. If you have a disability and the format of any material on the site interferes with your ability to access some information, please email the Department of Justice webmaster at webmaster@usdoj.gov or contact Alisa Finelli at 202.514.2007. To enable us to respond in a manner that will be of most help to you, please indicate the nature of the accessibility problem, your preferred format (electronic format (ASCII, etc.), standard print, large print, etc.), the web address of the requested material, and your full contact information so we can reach you if questions arise while fulfilling your request.
Looking beyond the spin of Big Pharma PR. But encouraging gossip. Come in and confide, you know you want to! “I’ll publish right or wrong. Fools are my theme, let satire be my song.” Email: jackfriday2011(at)hotmail.co.uk
Monday, July 02, 2012
USDOJ: GlaxoSmithKline (GSK) Press Conference - the documents
via justice.gov
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment